Phyllis Chew

Statistics

Publications

Citations

658

H-Index

Active since

1990

Affiliations

Baker Heart and Diabetes Institute(Current)

Monash University

Maastricht University

University of Glasgow

Genkyotex (Switzerland)

Phyllis Chew is an author at Baker Heart and Diabetes Institute specializing in inflammation, atherosclerosis molecular mechanisms, and endothelial dysfunction.

Publications per year

1990–2017

Publications

Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling

Stephen P. Gray, Elyse Di Marco, Kit Kennedy et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 189 citations · Full text

Life Sciences, Cell Biology, Pathobiology +16

Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse

Phyllis Chew, Derek Y.C. Yuen, Nada Stefanovic et al. · Diabetes · 2010 · 128 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease

Stephen P. Gray, Jay C. Jha, Kit Kennedy et al. · Diabetologia · 2017 · 107 citations · Full text

Medicine, Cardiology, Pharmacology +14

Site-Specific Antiatherogenic Effect of the Antioxidant Ebselen in the Diabetic Apolipoprotein E–Deficient Mouse

Phyllis Chew, Derek Y.C. Yuen, Philip Koh et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 92 citations

Life Sciences, Biochemistry, Cell Biology +17

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe −/− mice

Echeverria-Villalobos Marco, S. P. Gray, Phyllis Chew et al. · Diabetologia · 2013 · 59 citations · Full text

Veterinary Medicine, Cardiology, Pharmacology +17

1–5 of 8